173 related articles for article (PubMed ID: 33389074)
21. The implications of positive peritoneal lavage cytology in potentially resectable pancreatic cancer.
Yoshioka R; Saiura A; Koga R; Arita J; Takemura N; Ono Y; Yamamoto J; Yamaguchi T
World J Surg; 2012 Sep; 36(9):2187-91. PubMed ID: 22555286
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic cancer. Laparoscopic staging and peritoneal cytology.
Fernández-del Castillo CL; Warshaw AL
Surg Oncol Clin N Am; 1998 Jan; 7(1):135-42. PubMed ID: 9443991
[TBL] [Abstract][Full Text] [Related]
23. Value of peritoneal cytology in potentially resectable pancreatic cancer.
Yamada S; Fujii T; Kanda M; Sugimoto H; Nomoto S; Takeda S; Nakao A; Kodera Y
Br J Surg; 2013 Dec; 100(13):1791-6. PubMed ID: 24227366
[TBL] [Abstract][Full Text] [Related]
24. Role of staging laparoscopy with peritoneal lavage cytology in the treatment of locally advanced gastric cancer.
Nakagawa S; Nashimoto A; Yabusaki H
Gastric Cancer; 2007; 10(1):29-34. PubMed ID: 17334715
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of positive peritoneal cytology in resectable pancreatic cancer: a systemic review and meta-analysis.
Cao F; Li J; Li A; Li F
Oncotarget; 2017 Feb; 8(9):15004-15013. PubMed ID: 28122342
[TBL] [Abstract][Full Text] [Related]
26. Reappraisal of peritoneal washing cytology in 984 patients with pancreatic ductal adenocarcinoma who underwent margin-negative resection.
Satoi S; Murakami Y; Motoi F; Uemura K; Kawai M; Kurata M; Sho M; Matsumoto I; Yanagimoto H; Yamamoto T; Mizuma M; Unno M; Hashimoto Y; Hirono S; Yamaue H; Honda G; Nagai M; Nakajima Y; Shinzeki M; Fukumoto T; Kwon AH
J Gastrointest Surg; 2015 Jan; 19(1):6-14; discussion 14. PubMed ID: 25316482
[TBL] [Abstract][Full Text] [Related]
27. Peritoneal Lavage Cytology Following Neoadjuvant Chemotherapy for Gastric Adenocarcinoma: Low Yield in Detecting Peritoneal Metastases.
Young S; Ou R; Dehal A; O'Connor VV; DiFronzo LA
Am Surg; 2022 Jun; 88(6):1084-1089. PubMed ID: 33382351
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of intraoperative peritoneal cytology after neoadjuvant therapy for potentially resectable pancreatic cancer.
Aoki S; Mizuma M; Hayashi H; Yoshimachi S; Hata T; Miura T; Takadate T; Maeda S; Ariake K; Kawaguchi K; Masuda K; Ishida M; Ohtsuka H; Nakagawa K; Morikawa T; Motoi F; Unno M
Pancreatology; 2020 Dec; 20(8):1711-1717. PubMed ID: 33032923
[TBL] [Abstract][Full Text] [Related]
29. Peritoneal washings cytology combined with immunocytochemical staining in pancreatic cancer.
Nakao A; Oshima K; Takeda S; Kaneko T; Kanazumi N; Inoue S; Nomoto S; Kawase Y; Kasuya H
Hepatogastroenterology; 1999; 46(29):2974-7. PubMed ID: 10576385
[TBL] [Abstract][Full Text] [Related]
30. Predictive impacts of peritoneal washing cytology for surgical resection-intended pancreatic cancer cases: Establishment of planned staging laparoscopy criteria.
Tanaka N; Takami H; Hayashi M; Inokawa Y; Kurimoto K; Hattori N; Kanda M; Tanaka C; Nakayama G; Kodera Y
J Hepatobiliary Pancreat Sci; 2023 Nov; 30(11):1273-1281. PubMed ID: 37799038
[TBL] [Abstract][Full Text] [Related]
31. Prognostic indicators in pancreatic cancer patients undergoing total pancreatectomy.
Maeda S; Ariake K; Iseki M; Ohtsuka H; Mizuma M; Nakagawa K; Morikawa T; Hayashi H; Motoi F; Kamei T; Naitoh T; Unno M
Surg Today; 2020 May; 50(5):490-498. PubMed ID: 31768656
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy.
Hata T; Mizuma M; Masuda K; Chiba K; Ishida M; Ohtsuka H; Nakagawa K; Morikawa T; Kamei T; Unno M
Ann Surg Oncol; 2021 Apr; 28(4):2235-2245. PubMed ID: 33393045
[TBL] [Abstract][Full Text] [Related]
33. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.
Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K
World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841
[TBL] [Abstract][Full Text] [Related]
34. Staging Laparoscopy is Underutilized in the Management of Gastric Adenocarcinoma.
Groh EM; Gupta S; Brown ZJ; Enewold L; Gamble LA; Hernandez JM; Davis JL
Ann Surg Oncol; 2020 May; 27(5):1473-1479. PubMed ID: 31749079
[TBL] [Abstract][Full Text] [Related]
35. Conversion surgery for positive peritoneal washing cytology in pancreatic cancer.
Mitachi K; Ariake K; Motoi F; Unno M
BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31753819
[TBL] [Abstract][Full Text] [Related]
36. The critical role of peritoneal cytology in the staging of gastric cancer: an evidence-based review.
De Andrade JP; Mezhir JJ
J Surg Oncol; 2014 Sep; 110(3):291-7. PubMed ID: 24850538
[TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resection.
Kelly KJ; Wong J; Gladdy R; Moore-Dalal K; Woo Y; Gonen M; Brennan M; Allen P; Fong Y; Coit D
Ann Surg Oncol; 2009 Dec; 16(12):3333-9. PubMed ID: 19763694
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of staging laparoscopy for resectable pancreatic cancer on imaging and the therapeutic effect of systemic chemotherapy for positive peritoneal cytology.
Fukasawa M; Watanabe T; Tanaka H; Itoh A; Kimura N; Shibuya K; Yoshioka I; Murotani K; Hirabayashi K; Fujii T
J Hepatobiliary Pancreat Sci; 2023 Nov; 30(11):1261-1272. PubMed ID: 37750024
[TBL] [Abstract][Full Text] [Related]
39. Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma.
Merchant NB; Conlon KC; Saigo P; Dougherty E; Brennan MF
J Am Coll Surg; 1999 Apr; 188(4):421-6. PubMed ID: 10195727
[TBL] [Abstract][Full Text] [Related]
40. Intraoperative peritoneal lavage cytology offers prognostic significance for gastric cancer patients with curative resection.
Higaki E; Yanagi S; Gotohda N; Kinoshita T; Kuwata T; Nagino M; Ochiai A; Fujii S
Cancer Sci; 2017 May; 108(5):978-986. PubMed ID: 28256061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
